FORMICA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 326
EU - Europa 206
AS - Asia 128
AF - Africa 24
Totale 684
Nazione #
US - Stati Uniti d'America 324
SE - Svezia 49
IT - Italia 46
CN - Cina 45
GB - Regno Unito 38
SG - Singapore 32
VN - Vietnam 22
DE - Germania 21
IN - India 15
CH - Svizzera 11
RU - Federazione Russa 11
IE - Irlanda 10
CI - Costa d'Avorio 7
BG - Bulgaria 6
JO - Giordania 6
NG - Nigeria 6
TG - Togo 6
ZA - Sudafrica 4
EE - Estonia 3
FI - Finlandia 3
FR - Francia 3
ID - Indonesia 3
UA - Ucraina 3
CA - Canada 2
KR - Corea 2
LB - Libano 1
NL - Olanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
TR - Turchia 1
Totale 684
Città #
Chandler 58
Southend 34
Fairfield 30
Singapore 30
Ashburn 26
Houston 18
Woodbridge 18
Bologna 16
Seattle 14
Cambridge 13
Princeton 12
Bern 10
Dublin 10
Santa Clara 10
New York 8
Wilmington 8
Abidjan 7
Calderara Di Reno 7
Abeokuta 6
Amman 6
Florence 6
Lomé 6
Sofia 6
Beijing 5
Boardman 5
Turin 5
Ann Arbor 4
Nanjing 4
Pune 4
Helsinki 3
Jakarta 3
Jinan 3
Kuban 3
Medford 3
Redmond 3
Saint Petersburg 3
Westminster 3
Berlin 2
Bühl 2
Des Moines 2
Haikou 2
Hangzhou 2
Hefei 2
Lanzhou 2
Milan 2
Monmouth Junction 2
Nanchang 2
Ottawa 2
San Diego 2
Shenyang 2
Bremen 1
Changsha 1
Delhi 1
Dongguan 1
Dongyang 1
Falls Church 1
Frankfurt am Main 1
Groningen 1
Halhul 1
Hebei 1
Hounslow 1
Hyderabad 1
Jiaxing 1
Lisbon 1
Mahé 1
Moscow 1
Mountain View 1
Ningbo 1
Olalla 1
Padova 1
Radcliffe 1
Redwood City 1
Riccione 1
San Francisco 1
Saratov 1
Shanghai 1
Shenzhen 1
Tianjin 1
Xuzhou 1
Zhengzhou 1
Totale 466
Nome #
Mutational burden of resectable pancreatic cancer, as determined by whole transcriptome and whole exome sequencing, predicts a poor prognosis. 150
Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis 149
CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors 133
Higher number of known pancreatic cancer mutations highlighted by whole-transcripto- me and whole-exome sequencing predicts cli- nical outcome in early stage patients 113
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 100
Hacking pancreatic cancer: Present and future of personalized medicine 68
Totale 713
Categoria #
all - tutte 2.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.143


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202060 0 0 0 0 0 0 11 12 12 8 9 8
2020/2021116 11 0 1 0 19 19 4 5 8 9 4 36
2021/2022128 5 3 4 10 9 9 3 6 14 18 21 26
2022/2023203 18 34 10 20 20 16 3 11 31 7 21 12
2023/202461 4 8 3 6 5 22 0 5 1 3 4 0
2024/202579 9 27 15 12 10 4 2 0 0 0 0 0
Totale 713